Tag: refractory

Phase 3 Trial: Maribavir Yields Post-Transplant Benefits

by admin

May 8, 2023

The effects of maribavir (Levtencity) for the treatment of resistant or refractory post-transplant cytomegalovirus (CMV) infection persisted at 52-week follow-up ...

FDA Approves Pirtobrutinib for R/R Mantle Cell Lymphoma

by admin

January 29, 2023

The US Food and Drug Administration (FDA) has granted accelerated approval to pirtobrutinib (Jaypirca) for relapsed or refractory mantle cell ...

No Result

View All Result

Home
News
Pharmaceutical
Medicines & Healthy Lifestyle
Contact us

Tag: refractory

Phase 3 Trial: Maribavir Yields Post-Transplant Benefits

FDA Approves Pirtobrutinib for R/R Mantle Cell Lymphoma

Recommended

Half of Deaths From Homozygous FH Occur Before Age 32 Years

Tissue-Sparing Resection, Ablation Option for NET Liver Mets

Don't miss it

Biotechs face challenges as BIO convention returns to Boston

FDA Finalizes Stricter Guidance On Inorganic Arsenic Levels in Apple Juice

Surgical De-escalation in Low-Risk Cervical Cancer

CDSCO Panel Tells Dr. Reddy’s on Nerivio

Medicare holds firm on Alzheimer’s drug coverage policy

It’s Been Three Years. Can You Hear Me Now?

Navigate Site

Newsletter Sign Up